Selection of novel peptides homing the 4T1 CELL line: exploring alternative targets for triple negative breast cancer
The use of bacteriophages to select novel ligands has been widely explored for cancer therapy. Their application is most warranted in cancer subtypes lacking knowledge on how to target the cancer cells in question, such as the triple negative breast cancer, eventually leading to the development of a...
| Autor principal: | |
|---|---|
| Outros Autores: | , , , , |
| Formato: | article |
| Idioma: | eng |
| Publicado em: |
2016
|
| Assuntos: | |
| Texto completo: | http://hdl.handle.net/1822/42433 |
| País: | Portugal |
| Oai: | oai:repositorium.sdum.uminho.pt:1822/42433 |